Key result
Pulsed field ablation eliminates refractory scar-mediated VT with no recurrence at 3 months.
Why the study?
There is limited evidence on the efficacy of pulsed field ablation for treating ventricular tachycardia.
Does pulsed field ablation effectively eliminate ventricular tachycardia in patients with refractory scar-mediated structural heart disease?
Case Report (n=2)
Does pulsed field ablation effectively eliminate ventricular tachycardia in patients with refractory scar-mediated structural heart disease?
Pulsed field ablation shows promise as a viable adjunctive or rescue therapy for refractory scar-mediated ventricular tachycardia when traditional radiofrequency ablation fails.
Pulsed field ablation (PFA) is an innovative ablative technique increasingly employed in managing atrial fibrillation. It uses high-energy, nonthermal, nanosecond electrical pulses to induce irreversible electroporation, selectively disrupting cellular structures. These tailored waveforms minimize damage to surrounding nonmyocardial tissues, such as pulmonary veins, esophagus, and nerves.1 However, there is limited evidence on the efficacy of PFA for treating ventricular tachycardia (VT).
No takes yet. Share an insight, caveat, or question.
Prajapati et al. (2024) conducted a case report in Scar-mediated ventricular tachycardia (n=2). Pulsed field ablation was evaluated on Ventricular tachycardia recurrence at 3 months. Pulsed field ablation successfully eliminated refractory scar-mediated ventricular tachycardia in two patients, with no recurrence observed at 3-month follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: